← Back to Cognitive Deep Dive

NA-Selank

N-Acetyl Selank amidate — enhanced bioavailability variant

Protocol Summary

Route
Nasal / SubQ
Dose Range
200–500 mcg/day
Cycling
Similar to Selank: 14–21 days on, cycle off
Evidence Tier
animal

Primary Benefits

Safety Profile

Limited long-term data. Generally well-tolerated based on community reports.

Research Findings

No findings yet. The weekly research pipeline will populate this section.